speb/financial-data huggingface dataset:
ZBIO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -69000.00
ZBIO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 13178000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 857000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 0.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 196428000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 40043000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 10717000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 180000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 180000.00
ZBIO income_statement (quarterly, 2025-09-30) — Net Income: -51499000.00
ZBIO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -51499000.00
ZBIO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -51499000.00
ZBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -51499000.00
ZBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -51499000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -51499000.00
ZBIO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -51499000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 45043000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Net PPE: 857000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
ZBIO cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 196428000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 837000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 12882000.00
ZBIO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -42569000.00
ZBIO income_statement (quarterly, 2025-09-30) — Normalized Income: -46499000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -41125000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
ZBIO income_statement (quarterly, 2025-09-30) — Operating Income: -47580000.00
ZBIO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 42213465.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5758000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -69000.00
ZBIO income_statement (quarterly, 2025-09-30) — Other Gand A: 4374000.00
ZBIO income_statement (quarterly, 2025-09-30) — Other Income Expense: -3919000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 6884000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 83000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 72989000.00
ZBIO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1081000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Other Properties: 857000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 175319000.00
ZBIO income_statement (quarterly, 2025-09-30) — Other Special Charges: 5000000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Payables: 6444000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 43046000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 8757000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
ZBIO cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
ZBIO income_statement (quarterly, 2025-09-30) — Pretax Income: -51499000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 940000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -59195000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
ZBIO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 11000.00
ZBIO income_statement (quarterly, 2025-09-30) — Research And Development: 34402000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 0.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -524686000.00
ZBIO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 8804000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 104238000.00
ZBIO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 13178000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Share Issued: 42213465.00
ZBIO income_statement (quarterly, 2025-09-30) — Special Income Charges: -5000000.00
ZBIO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 7336000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 196428000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 196428000.00
ZBIO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ZBIO income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
ZBIO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Assets: 322018000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 196428000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Debt: 798000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 196428000.00
ZBIO income_statement (quarterly, 2025-09-30) — Total Expenses: 47580000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 125590000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 25376000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 73169000.00
ZBIO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -52580000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
ZBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -5000000.00
ZBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -5000000.00
ZBIO balance_sheet (quarterly, 2025-09-30) — Working Capital: 244221000.00
ZBIO income_statement (annual, 2025-12-31) — +Operating Expense: 221385000.00
ZBIO income_statement (quarterly, 2025-12-31) — +Operating Expense: 71312000.00
ZBIO income_statement (annual, 2025-12-31) — +Total Revenue: 10000000.00
ZBIO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
ZBIO balance_sheet (annual, 2025-12-31) — Accounts Payable: 7111000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 7111000.00
ZBIO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1007331000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1007331000.00
ZBIO cash_flow (annual, 2025-12-31) — Amortization Of Securities: -1931000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -421000.00
ZBIO income_statement (annual, 2025-12-31) — Basic Average Shares: 44730052.00
ZBIO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 52999848.00
ZBIO income_statement (annual, 2025-12-31) — Basic EPS: -8.44
ZBIO income_statement (quarterly, 2025-12-31) — Basic EPS: -4.54
ZBIO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 319832000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 115565000.00
ZBIO cash_flow (annual, 2025-12-31) — Capital Expenditure: -35018000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -30000000.00
ZBIO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1326000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1326000.00
ZBIO balance_sheet (annual, 2025-12-31) — Capital Stock: 5000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5000.00
ZBIO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 110641000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 110641000.00
ZBIO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 343192000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 343192000.00
ZBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 215280000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 140843000.00
ZBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -251886000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -93364000.00
ZBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -172333000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -52414000.00
ZBIO cash_flow (annual, 2025-12-31) — Change In Account Payable: -10043000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1116000.00
ZBIO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 15052000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 9801000.00
ZBIO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -902000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -245000.00
ZBIO cash_flow (annual, 2025-12-31) — Change In Payable: -10043000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Change In Payable: 1116000.00
ZBIO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 5009000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 10917000.00
ZBIO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -3156000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -2357000.00
ZBIO cash_flow (annual, 2025-12-31) — Change In Working Capital: 951000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 8315000.00
ZBIO cash_flow (annual, 2025-12-31) — Changes In Cash: -208939000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4935000.00
ZBIO balance_sheet (annual, 2025-12-31) — Common Stock: 5000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Common Stock: 5000.00
ZBIO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 242144000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 242144000.00
ZBIO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 148573000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 148573000.00
ZBIO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 41225000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 41225000.00
ZBIO balance_sheet (annual, 2025-12-31) — Current Assets: 351171000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Current Assets: 351171000.00
ZBIO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1115000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1115000.00
ZBIO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1115000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1115000.00
ZBIO balance_sheet (annual, 2025-12-31) — Current Liabilities: 62649000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 62649000.00
ZBIO cash_flow (annual, 2025-12-31) — Depreciation: 56000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Depreciation: 10000.00
ZBIO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 56000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 10000.00
ZBIO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 56000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 10000.00
ZBIO income_statement (annual, 2025-12-31) — Diluted Average Shares: 44730052.00
ZBIO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 52999848.00
ZBIO income_statement (annual, 2025-12-31) — Diluted EPS: -8.44
ZBIO income_statement (quarterly, 2025-12-31) — Diluted EPS: -4.54
ZBIO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -377737000.00
ZBIO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -240442000.00
ZBIO income_statement (annual, 2025-12-31) — EBIT: -370489000.00
ZBIO income_statement (quarterly, 2025-12-31) — EBIT: -230416000.00
ZBIO income_statement (annual, 2025-12-31) — EBITDA: -370433000.00
ZBIO income_statement (quarterly, 2025-12-31) — EBITDA: -230406000.00
ZBIO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -252000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 11000.00
ZBIO cash_flow (annual, 2025-12-31) — End Cash Position: 110641000.00
ZBIO cash_flow (quarterly, 2025-12-31) — End Cash Position: 110641000.00
ZBIO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 215280000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 140843000.00
ZBIO cash_flow (annual, 2025-12-31) — Free Cash Flow: -207351000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -82414000.00
ZBIO cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 107000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
ZBIO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -64000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -64000.00
ZBIO income_statement (annual, 2025-12-31) — General And Administrative Expense: 53322000.00
ZBIO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 15592000.00
ZBIO balance_sheet (annual, 2025-12-31) — Gross PPE: 1388000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1388000.00
ZBIO balance_sheet (annual, 2025-12-31) — Income Tax Payable: 118000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 118000.00
ZBIO income_statement (annual, 2025-12-31) — Interest Expense: 7327000.00
ZBIO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 7327000.00
ZBIO income_statement (annual, 2025-12-31) — Interest Income: 12151000.00
ZBIO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 12151000.00
ZBIO balance_sheet (annual, 2025-12-31) — Invested Capital: 242144000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 242144000.00
ZBIO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -251886000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -93364000.00
ZBIO balance_sheet (annual, 2025-12-31) — Investments And Advances: 17272000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 17272000.00
ZBIO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 148573000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 148573000.00
ZBIO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 211000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 211000.00
ZBIO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 211000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 211000.00
ZBIO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 148573000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 148573000.00
ZBIO income_statement (annual, 2025-12-31) — Net Income: -377737000.00
ZBIO income_statement (quarterly, 2025-12-31) — Net Income: -240442000.00
ZBIO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -377737000.00
ZBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -240442000.00
ZBIO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -377737000.00
ZBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -240442000.00
ZBIO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -377737000.00
ZBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -240442000.00
ZBIO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -377737000.00
ZBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -240442000.00
ZBIO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -377737000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -240442000.00
ZBIO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -377737000.00
ZBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -240442000.00
ZBIO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -35000000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -30000000.00
ZBIO income_statement (annual, 2025-12-31) — Net Interest Income: 4824000.00
ZBIO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -216868000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -63364000.00
ZBIO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 4824000.00
ZBIO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 62335000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 65659000.00
ZBIO balance_sheet (annual, 2025-12-31) — Net PPE: 1388000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 1388000.00
ZBIO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -18000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 0.00
ZBIO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
ZBIO cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
ZBIO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 242144000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 242144000.00
ZBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 709000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 709000.00
ZBIO balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 12882000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 12882000.00
ZBIO income_statement (annual, 2025-12-31) — Normalized EBITDA: -198761000.00
ZBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -63734000.00
ZBIO income_statement (annual, 2025-12-31) — Normalized Income: -206116501.60
ZBIO income_statement (quarterly, 2025-12-31) — Normalized Income: -108771120.00
ZBIO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -172333000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -52414000.00
ZBIO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 107000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
ZBIO income_statement (annual, 2025-12-31) — Operating Income: -211385000.00
ZBIO income_statement (quarterly, 2025-12-31) — Operating Income: -71312000.00
ZBIO income_statement (annual, 2025-12-31) — Operating Revenue: 10000000.00
ZBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
ZBIO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 54485518.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 54485518.00
ZBIO balance_sheet (annual, 2025-12-31) — Other Current Assets: 7979000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 7979000.00
ZBIO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -64000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -64000.00
ZBIO income_statement (annual, 2025-12-31) — Other Gand A: 16766000.00
ZBIO income_statement (quarterly, 2025-12-31) — Other Gand A: 4297000.00
ZBIO income_statement (annual, 2025-12-31) — Other Income Expense: -171255000.00
ZBIO income_statement (quarterly, 2025-12-31) — Other Income Expense: -173848000.00
ZBIO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 179874000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 172544000.00
ZBIO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 218000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 218000.00
ZBIO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 78636000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 78636000.00
ZBIO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 417000.00
ZBIO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -7176000.00
ZBIO balance_sheet (annual, 2025-12-31) — Other Properties: 1388000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Other Properties: 1388000.00
ZBIO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 232551000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 232551000.00
ZBIO income_statement (annual, 2025-12-31) — Other Special Charges: 171672000.00
ZBIO income_statement (quarterly, 2025-12-31) — Other Special Charges: 166672000.00
ZBIO balance_sheet (annual, 2025-12-31) — Payables: 7229000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Payables: 7229000.00
ZBIO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 48454000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 48454000.00
ZBIO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 13080000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 13080000.00
ZBIO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ZBIO cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
ZBIO cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
ZBIO income_statement (annual, 2025-12-31) — Pretax Income: -377816000.00
ZBIO income_statement (quarterly, 2025-12-31) — Pretax Income: -240336000.00
ZBIO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 4372000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1611000.00
ZBIO cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -35000000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -30000000.00
ZBIO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -417755000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -132893000.00
ZBIO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -18000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
ZBIO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 56000.00
ZBIO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 10000.00
ZBIO income_statement (annual, 2025-12-31) — Research And Development: 168063000.00
ZBIO income_statement (quarterly, 2025-12-31) — Research And Development: 55720000.00
ZBIO balance_sheet (annual, 2025-12-31) — Restricted Cash: 0.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 0.00
ZBIO balance_sheet (annual, 2025-12-31) — Retained Earnings: -765128000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -765128000.00
ZBIO income_statement (annual, 2025-12-31) — Salaries And Wages: 36556000.00
ZBIO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 11295000.00
ZBIO cash_flow (annual, 2025-12-31) — Sale Of Investment: 200887000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 69529000.00
ZBIO income_statement (annual, 2025-12-31) — Selling General And Administration: 53322000.00
ZBIO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 15592000.00
ZBIO balance_sheet (annual, 2025-12-31) — Share Issued: 54485518.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Share Issued: 54485518.00
ZBIO income_statement (annual, 2025-12-31) — Special Income Charges: -171672000.00
ZBIO income_statement (quarterly, 2025-12-31) — Special Income Charges: -166672000.00
ZBIO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 26347000.00
ZBIO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 7580000.00
ZBIO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 242144000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 242144000.00
ZBIO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 242144000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 242144000.00
ZBIO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -51501.60
ZBIO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -35001120.00
ZBIO income_statement (annual, 2025-12-31) — Tax Provision: -79000.00
ZBIO income_statement (quarterly, 2025-12-31) — Tax Provision: 106000.00
ZBIO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
ZBIO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
ZBIO balance_sheet (annual, 2025-12-31) — Total Assets: 383640000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Assets: 383640000.00
ZBIO balance_sheet (annual, 2025-12-31) — Total Capitalization: 242144000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 242144000.00
ZBIO balance_sheet (annual, 2025-12-31) — Total Debt: 1326000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Debt: 1326000.00
ZBIO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 242144000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 242144000.00
ZBIO income_statement (annual, 2025-12-31) — Total Expenses: 221385000.00
ZBIO income_statement (quarterly, 2025-12-31) — Total Expenses: 71312000.00
ZBIO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 141496000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 141496000.00
ZBIO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 32469000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 32469000.00
ZBIO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 78847000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 78847000.00
ZBIO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -383057000.00
ZBIO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -237984000.00
ZBIO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 118000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 118000.00
ZBIO income_statement (annual, 2025-12-31) — Total Unusual Items: -171672000.00
ZBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -166672000.00
ZBIO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -171672000.00
ZBIO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -166672000.00
ZBIO balance_sheet (annual, 2025-12-31) — Working Capital: 288522000.00
ZBIO balance_sheet (quarterly, 2025-12-31) — Working Capital: 288522000.00
ZBIO income_statement (quarterly, 2026-03-31) — +Operating Expense: 77350000.00
ZBIO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 8944000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1182315000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -110000.00
ZBIO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 55624631.00
ZBIO income_statement (quarterly, 2026-03-31) — Basic EPS: -1.46
ZBIO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 110641000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1114000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 500224000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 717205000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 433479000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 31611000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -75196000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1795000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -4963000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -211000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Change In Payable: 1795000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3168000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -6482000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -9861000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 389894000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Common Stock: 6000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 335829000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 165532000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 45444000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Current Assets: 730164000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1037000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1037000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 61161000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Depreciation: 6000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 6000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6000.00
ZBIO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 55624631.00
ZBIO income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.46
ZBIO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -80987000.00
ZBIO income_statement (quarterly, 2026-03-31) — EBIT: -74356000.00
ZBIO income_statement (quarterly, 2026-03-31) — EBITDA: -74350000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -311000.00
ZBIO cash_flow (quarterly, 2026-03-31) — End Cash Position: 500224000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 433479000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -75198000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -377000.00
ZBIO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 16911000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1118000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 118000.00
ZBIO income_statement (quarterly, 2026-03-31) — Interest Expense: 6631000.00
ZBIO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6631000.00
ZBIO income_statement (quarterly, 2026-03-31) — Interest Income: 3018000.00
ZBIO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3018000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 601544000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 31611000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1340000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 165532000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 267500000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 77000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 265715000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 265792000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 267500000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 165532000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Income: -80987000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -80987000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -80987000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -80987000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -80987000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -80987000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -80987000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Interest Income: -3613000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 31613000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 267500000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 267500000.00
ZBIO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3613000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -512000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Net PPE: 1118000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 335829000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 439000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 14535000.00
ZBIO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -74350000.00
ZBIO income_statement (quarterly, 2026-03-31) — Normalized Income: -80987000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -75196000.00
ZBIO income_statement (quarterly, 2026-03-31) — Operating Income: -77350000.00
ZBIO income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 62383377.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 12959000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -377000.00
ZBIO income_statement (quarterly, 2026-03-31) — Other Gand A: 4306000.00
ZBIO income_statement (quarterly, 2026-03-31) — Other Income Expense: -24000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 6561000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 86000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 84900000.00
ZBIO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -24000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Other Properties: 1118000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 216981000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Payables: 9062000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 54506000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 5618000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
ZBIO income_statement (quarterly, 2026-03-31) — Pretax Income: -80987000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 959000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -76520000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2000.00
ZBIO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 6000.00
ZBIO income_statement (quarterly, 2026-03-31) — Research And Development: 60439000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -846115000.00
ZBIO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 12605000.00
ZBIO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 108133000.00
ZBIO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 16911000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Share Issued: 62383377.00
ZBIO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 9195000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 335829000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 335829000.00
ZBIO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
ZBIO income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
ZBIO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Assets: 747682000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 601544000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Debt: 266829000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 335829000.00
ZBIO income_statement (quarterly, 2026-03-31) — Total Expenses: 77350000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 411853000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 17518000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 350692000.00
ZBIO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -77350000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 118000.00
ZBIO balance_sheet (quarterly, 2026-03-31) — Working Capital: 669003000.00
ZBNI.V income_statement (annual, 2021-12-31) — +Operating Expense: 471424.00
ZBNI.V income_statement (annual, 2021-12-31) — +Total Revenue: 0.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Accounts Payable: 186663.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 301458.00
ZBNI.V income_statement (annual, 2021-12-31) — Basic Average Shares: 40355917.00
ZBNI.V income_statement (annual, 2021-12-31) — Basic EPS: -0.03
ZBNI.V cash_flow (annual, 2021-12-31) — Beginning Cash Position: 0.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Capital Stock: 7310586.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 1922185.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 1922185.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Cash Financial: 1922185.00
ZBNI.V cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: 2700710.00
ZBNI.V cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -277827.00
ZBNI.V cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: -542756.00
ZBNI.V cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: -220940.00
ZBNI.V cash_flow (annual, 2021-12-31) — Change In Prepaid Assets: -82222.00
ZBNI.V cash_flow (annual, 2021-12-31) — Change In Receivables: -32124.00
ZBNI.V cash_flow (annual, 2021-12-31) — Change In Working Capital: -335286.00
ZBNI.V cash_flow (annual, 2021-12-31) — Changes In Cash: 1880127.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Common Stock: 7310586.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Common Stock Equity: 5644049.00
ZBNI.V cash_flow (annual, 2021-12-31) — Common Stock Issuance: 2800000.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Current Assets: 2009398.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Current Liabilities: 505001.00
ZBNI.V income_statement (annual, 2021-12-31) — Diluted Average Shares: 40355917.00
ZBNI.V income_statement (annual, 2021-12-31) — Diluted EPS: -0.03
ZBNI.V income_statement (annual, 2021-12-31) — Diluted NI Availto Com Stockholders: -1003563.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 318338.00
ZBNI.V income_statement (annual, 2021-12-31) — EBIT: -957924.00
ZBNI.V income_statement (annual, 2021-12-31) — EBITDA: -957924.00
ZBNI.V cash_flow (annual, 2021-12-31) — Effect Of Exchange Rate Changes: 42058.00
ZBNI.V cash_flow (annual, 2021-12-31) — End Cash Position: 1922185.00
ZBNI.V cash_flow (annual, 2021-12-31) — Financing Cash Flow: 2700710.00
ZBNI.V cash_flow (annual, 2021-12-31) — Free Cash Flow: -542756.00
ZBNI.V cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -182145.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Gains Losses Not Affecting Retained Earnings: 53870.00
ZBNI.V income_statement (annual, 2021-12-31) — General And Administrative Expense: 449847.00
ZBNI.V income_statement (annual, 2021-12-31) — Interest Expense: 45639.00
ZBNI.V income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 45639.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Invested Capital: 6267923.00
ZBNI.V cash_flow (annual, 2021-12-31) — Investing Cash Flow: -277827.00
ZBNI.V cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 2800000.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Long Term Debt: 623874.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 623874.00
ZBNI.V cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 134198.00
ZBNI.V cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 2800000.00
ZBNI.V cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Income: -1003563.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Income Common Stockholders: -1003563.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Income Continuous Operations: -1003563.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Income From Continuing And Discontinued Operation: -1003563.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Income From Continuing Operation Net Minority Interest: -1003563.00
ZBNI.V cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: -1003563.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Income Including Noncontrolling Interests: -1003563.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Interest Income: -46343.00
ZBNI.V income_statement (annual, 2021-12-31) — Net Non Operating Interest Income Expense: -46343.00
ZBNI.V cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -119290.00
ZBNI.V cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -412025.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Net PPE: 4736393.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 5644049.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 27133.00
ZBNI.V income_statement (annual, 2021-12-31) — Normalized EBITDA: -289983.00
ZBNI.V income_statement (annual, 2021-12-31) — Normalized Income: -335622.00
ZBNI.V cash_flow (annual, 2021-12-31) — Operating Cash Flow: -542756.00
ZBNI.V cash_flow (annual, 2021-12-31) — Operating Gains Losses: -182145.00
ZBNI.V income_statement (annual, 2021-12-31) — Operating Income: -471424.00
ZBNI.V income_statement (annual, 2021-12-31) — Operating Revenue: 0.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 54884786.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Other Equity Adjustments: 53870.00
ZBNI.V income_statement (annual, 2021-12-31) — Other Gand A: 160189.00
ZBNI.V income_statement (annual, 2021-12-31) — Other Income Expense: -485796.00
ZBNI.V cash_flow (annual, 2021-12-31) — Other Non Cash Items: 713580.00
ZBNI.V income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 182145.00
ZBNI.V income_statement (annual, 2021-12-31) — Other Operating Expenses: 21577.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Payables: 505001.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 505001.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Prepaid Assets: 55089.00
ZBNI.V income_statement (annual, 2021-12-31) — Pretax Income: -1003563.00
ZBNI.V cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 20000.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Receivables: 32124.00
ZBNI.V income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 667941.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Retained Earnings: -2021865.00
ZBNI.V income_statement (annual, 2021-12-31) — Salaries And Wages: 289658.00
ZBNI.V cash_flow (annual, 2021-12-31) — Sale Of Business: 134198.00
ZBNI.V income_statement (annual, 2021-12-31) — Securities Amortization: 45639.00
ZBNI.V income_statement (annual, 2021-12-31) — Selling General And Administration: 449847.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Share Issued: 54884786.00
ZBNI.V income_statement (annual, 2021-12-31) — Special Income Charges: -667941.00
ZBNI.V cash_flow (annual, 2021-12-31) — Stock Based Compensation: 264658.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Stockholders Equity: 5644049.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Tangible Book Value: 5644049.00
ZBNI.V income_statement (annual, 2021-12-31) — Tax Effect Of Unusual Items: 0.00
ZBNI.V income_statement (annual, 2021-12-31) — Tax Rate For Calcs: 0.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Taxes Receivable: 32124.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Total Assets: 6772924.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Total Capitalization: 6267923.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Total Debt: 623874.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 5644049.00
ZBNI.V income_statement (annual, 2021-12-31) — Total Expenses: 471424.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 1128875.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 4763526.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 623874.00
ZBNI.V income_statement (annual, 2021-12-31) — Total Other Finance Cost: 704.00
ZBNI.V income_statement (annual, 2021-12-31) — Total Unusual Items: -667941.00
ZBNI.V income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -667941.00
ZBNI.V balance_sheet (annual, 2021-12-31) — Working Capital: 1504397.00
ZBNI.V income_statement (annual, 2021-12-31) — Write Off: 0.00
ZBNI.V income_statement (annual, 2022-12-31) — +Operating Expense: 711714.00
ZBNI.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 121591.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 631634.00
ZBNI.V cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
ZBNI.V income_statement (annual, 2022-12-31) — Basic Average Shares: 54904877.00
ZBNI.V income_statement (annual, 2022-12-31) — Basic EPS: -0.02
ZBNI.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1922185.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Capital Stock: 7327047.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 424380.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 424380.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Cash Financial: 424380.00
ZBNI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 5796.00
ZBNI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1018456.00
ZBNI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -484658.00
ZBNI.V cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 19118.00
ZBNI.V cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -19035.00
ZBNI.V cash_flow (annual, 2022-12-31) — Change In Receivables: -78697.00
ZBNI.V cash_flow (annual, 2022-12-31) — Change In Working Capital: -78614.00
ZBNI.V cash_flow (annual, 2022-12-31) — Changes In Cash: -1497318.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Common Stock: 7327047.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 5006951.00
ZBNI.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Current Assets: 551989.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Current Debt: 802901.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 802901.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 1045315.00
ZBNI.V balance_sheet (annual, 2022-12-31) — Current Notes Payable: 802901.00